OS Therapies Inc (OSTX) Corporate Subsidiaries
OS Therapies Inc (OSTX) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OSTX
CIK: 1795091
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
MaloneBailey, LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerMariano Frugone
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 3 | 2026-10-05 | 2026-09-29 | 3 Filing | 0001213900-26-106858 | View SEC Doc Filr Page |
| 3 | 2026-10-05 | 2026-09-29 | 3 Filing | 0001213900-26-106857 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-09-29 | CURRENT REPORT | 0001213900-26-106849 | View SEC Doc Filr Page |
| S-8 | 2026-09-21 | — | REGISTRATION STATEMENT | 0001213900-26-101526 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-10 | CURRENT REPORT | 0001213900-26-098880 | View SEC Doc Filr Page |
| 424B7 | 2026-09-10 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-098870 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | CURRENT REPORT | 0001213900-26-098403 | View SEC Doc Filr Page |
| D | 2026-08-25 | — | D Filing | 0000921895-26-002306 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-21 | CURRENT REPORT | 0001213900-26-092651 | View SEC Doc Filr Page |
| 424B5 | 2026-08-21 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-092627 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-090238 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-06 | CURRENT REPORT | 0001213900-26-088435 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-07-31 | CURRENT REPORT | 0001213900-26-086150 | View SEC Doc Filr Page |
| 424B5 | 2026-08-06 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-086149 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-23 | CURRENT REPORT | 0001213900-26-082876 | View SEC Doc Filr Page |
| ARS | 2026-07-24 | 2025-12-31 | ARS | 0001213900-26-081423 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-24 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-081417 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-24 | 2026-09-09 | PROXY STATEMENT | 0001213900-26-081390 | View SEC Doc Filr Page |
| 3 | 2026-07-23 | 2026-07-01 | 3 Filing | 0001213900-26-080878 | View SEC Doc Filr Page |
| D | 2026-07-16 | — | D Filing | 0001795091-26-000003 | View SEC Doc Filr Page |
| 8-K/A | 2026-07-07 | 2026-06-30 | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-26-075781 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-30 | CURRENT REPORT | 0001213900-26-075013 | View SEC Doc Filr Page |
| 10-Q | 2026-05-18 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-058070 | View SEC Doc Filr Page |
| 5/A | 2026-05-15 | 2024-12-31 | 5/A Filing | 0001213900-26-058022 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NOTIFICATION OF LATE FILING | 0001213900-26-057790 | View SEC Doc Filr Page |